Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

News Daily News

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Michael O'Riordan

October 17, 2016

News Opinion Fellow Talk

Hemodynamics Galore: What I Learned at the C3 Summit

Tiffany Patterson, MBBS

July 27, 2016

News Daily News

FDA Warns of Class I Recall for HeartWare VAD Batteries

Michael O'Riordan

June 29, 2016

Presentation TVT 2016

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Presenter: Frank van der kley, MD

June 17, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Industry News

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

April 28, 2016

News Industry News

Biotronik launches 2 new studies

August 13, 2015

News Industry News

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

August 10, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

Presentation TCT 2014

TCT 78: Predictors of Survival in Patients Undergoing Transcatheter Aortic Valve Closure for Significant Left Ventricular Assist Device-Associated Aortic Insufficiency

Presenter: John C Criscione, Elmir Omerovic, Elizabeth Retzer

September 16, 2014

News Conference News ESC 2012

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

August 29, 2012

Advertisement

Ischemic Cardiomyopathy Patients Can Benefit From Myocardial Unloading, Study Suggests

Hemodynamics Galore: What I Learned at the C3 Summit

FDA Warns of Class I Recall for HeartWare VAD Batteries

TVT 1130: Transcatheter Aortic Valve Implantation in a Heart-Failure Patient With a Left Ventricular Assist Device and Severe Aortic Regurgitation

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

Biotronik launches 2 new studies

HeartWare Completes Enrollment In ENDURANCE2 Supplemental Destination Therapy Trial

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

TCT 78: Predictors of Survival in Patients Undergoing Transcatheter Aortic Valve Closure for Significant Left Ventricular Assist Device-Associated Aortic Insufficiency

Renal Denervation Shows Promise for Heart Failure, Ongoing Success Against Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content